Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 20, 2010, Pages 9083-9087

  Maas, Coen ^a   Meijers, Joost C M ^b   Marquart, J Arnoud ^b   Bakhtiari, Kamran ^b   Weeterings, Cees ^a   De Groot, Philip G ^a   Urbanus, Rolf T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Coagulation; Coagulation factor V; Coagulation factor XI; Feedback activation

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; KININOGEN; PROTEIN S; THROMBIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD CLOTTING; CONTROLLED STUDY; FEEDBACK SYSTEM; MUTATIONAL ANALYSIS; PLASMA; PRIORITY JOURNAL; PROTEIN DEPLETION;

ANALYSIS OF VARIANCE; BLOOD COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VA; FACTOR XI; HEMOSTASIS; HUMANS; PLASMA; PROTEIN BINDING; SURFACE PLASMON RESONANCE; THROMBIN;

EID: 77952702663     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1004741107     Document Type: Article

References (27)

1. Davie EW, Ratnoff OD (1964) Waterfall sequence for intrinsic blood clotting. Science 145:1310-1312.
2. MacFarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498-499.
3. Renne T, et al. (2005) Defective thrombus formation inmice lacking coagulation factor XII. J Exp Med 202:271-281. (Pubitemid 41043823)
4. Doggen CJ, Rosendaal FR, Meijers JC (2006) Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 108:4045-4051.
5. Cichon S, et al. (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79:1098-1104. (Pubitemid 44853481)
6. Maas C, et al. (2008) Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 118:3208-3218.
7. Naito K, Fujikawa K (1991) Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266:7353-7358. (Pubitemid 21906372)
8. Gailani D, Broze GJ, Jr (1991) Factor XI activation in a revised model of blood coagulation. Science 253:909-912. (Pubitemid 21917236)
9. von dem Borne PA, Meijers JC, Bouma BN (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86:3035-3042.
10. von dem Borne PA, et al. (1997) Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 99:2323-2327.
11. Pedicord DL, Seiffert D, Blat Y (2007) Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci USA 104:12855-12860. (Pubitemid 47255244)
12. Wielders SJ, Beguin S, Hemker HC, Lindhout T (2004) Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Arterioscler Thromb Vasc Biol 24:1138-1142. (Pubitemid 38737843)
13. Kravtsov DV, et al. (2009) Factor XI contributes to thrombin generation in the absence of factor XII. Blood 114:452-458.
14. Thompson RE, Mandle R, Jr, Kaplan AP (1977) Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 60:1376-1380. (Pubitemid 8238653)
15. Thompson RE, Mandle R, Jr, Kaplan AP (1979) Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci USA 76:4862-4866. (Pubitemid 10229085)
16. Krishnaswamy S, Mann KG (1988) The binding of factor Va to phospholipid vesicles. J Biol Chem 263:5714-5723.
17. Nesheim ME, Taswell JB, Mann KG (1979) The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 254:10952-10962.
18. Rosing J, et al. (1980) The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 255:274-283. (Pubitemid 10146055)
19. Renne T, Gailani D, Meijers JC, Muller-Esterl W (2002) Characterization of the H-kininogen- binding site on factor XI: a comparison of factor XI and plasma prekallikrein. J Biol Chem 277:4892-4899. (Pubitemid 34968525)
20. Donaldson VH, Kleniewski J, Saito H, Sayed JK (1977) Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest 60:571-583. (Pubitemid 8180861)
21. Mosnier LO, Bouma BN (2006) Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol 26:2445-2453.
22. Vandenbroucke JP, et al. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453-1457.
23. Bertina RM, et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67. (Pubitemid 24144355)
24. Hackeng TM, van 't Veer C, Meijers JC, Bouma BN (1994) Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 269:21051-21058.
25. Kisiel W (1979) Human plasma protein C: Isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 64:761-769. (Pubitemid 10223754)
26. Koedam JA, Meijers JC, Sixma JJ, Bouma BN (1988) Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236-1243.
27. Meijers JC, Mulvihill ER, Davie EW, Chung DW (1992) Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 31:4680-4684.